McKinsey & Company's conduct and conflicts at the heart of the opioid epidemic : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Seventeenth Congress, second session, April 27, 2022.

Author/creator United States
Format Electronic
PublicationWashington : U.S. Government Publishing Office, 2022.
Description1 online resource (iii, 52 pages)
Supplemental Contenthttps://purl.fdlp.gov/GPO/gpo183162
Subjects

General noteAccess ID (govinfo): CHRG-117hhrg47526.
General note"Serial no. 117-79."
General noteGPO Cataloging Record Distribution Program (CRDP).
Performer Hearing witnesses: Mr. Bob Sternfels, Global Managing Partner, McKinsey & Company; The Honorable Maura Healey, Attorney General, Commonwealth of Massachusetts, in Joint Testimony with Ms. Gillian Feiner, Senior Enforcement Counsel, Massachusetts Attorney General's Office; Mr. Uttam Dhillons, Chair, Regulatory Defense, Compliance & White Collar Practice Group, Michael Best & Friedrich LLP; Professor Jessica Tillipman, Assistant Dean for Government Procurement Law Studies, George Washington University Law School.
Date/time/place of a event noteDate of hearing: 2022-04-27.
Source of descriptionDescription based on online resource; title from PDF title page (govinfo, viewed June 7, 2022).
Issued in other formPrint version: United States. Congress. House. Committee on Oversight and Reform. McKinsey & Company's conduct and conflicts at the heart of the opioid epidemic
Genre/formLegislative hearings.
Standard identifier# 47-526 (GPO jacket number)
Technical rpt numberSerial no. 117-79 (United States. Congress. House. Committee on Oversight and Reform)
GPO item number1016-C (online)
Govt. docs number Y 4.OV 2:117-79